Raman Bahal
Associate Professor/Pharmaceutical Science

Are you Raman Bahal?

How to update your information.
Dual-modality poly-L-histidine nanoparticles to deliver peptide nucleic acids and paclitaxel for in vivo cancer therapy
2022
Research Type: Patent and Intellectual Property

Microrna-33 inhibitors and use thereof in the treatment of pulmonary fibrosis” Provisional patent
2022
Research Type: Patent and Intellectual Property

Composition of tunable carbohydrate nucleic acid conjugates for enhanced liver and kidney-specific targeting
2022
Research Type: Patent and Intellectual Property

The growth of siRNA-based therapeutics: Updated clinical studies
2021
May Zhang, xiaobo zhong, Raman Bahal, Theodore Rasmussen, Jose E Manautou
Research Type: Journal Article

Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
2021
S Malik, K C Shih, A Vikram, Yang Liu, Chi-ming Chen, A Wahane, Mu-ping Nieh, Raman Bahal, R R Gaddam
Research Type: Journal Article

Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy.
2021
R Verma, K Dhuri, R N Vyas, Raman Bahal, L Blumenfeld
Research Type: Journal Article

Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids.
2021
Raman Bahal, W M Saltzman, S Malik
Research Type: Journal Article

Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
2021
R R Gaddam, K Dhuri, Raman Bahal, A Vikram, F J Slack
Research Type: Journal Article

PLA-HPG particles delivered multiple oncomiRs inhibitors for cancer treatment
2021
Research Type: Patent and Intellectual Property

Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
2020
J C Deacon, Raman Bahal, F N Barrera, A A Svoronos, M C Pereira, D M Engelman, P M Glazer, D DiMaio, M Bosenberg
Research Type: Journal Article

Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.
2020
D T Braddock, J Lim, S Malik, F J Slack, Raman Bahal
Research Type: Journal Article

Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.
2020
H Pham, D M Engelman, P M Glazer, Yang Liu, Raman Bahal, A R Kaplan, S Oyaghire
Research Type: Journal Article

Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids.
2020
S Malik, Raman Bahal, F J Slack
Research Type: Journal Article

Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db mice.
2020
K Irani, A Vikram, M Kassan, Y R Kim, K Dhuri, J S Jacobs, V P Jacobsen, R Roghair, Q Li, M Gabani, Raman Bahal, R R Gaddam, S Kumar
Research Type: Journal Article

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development.
2020
A Gupta, A Vikram, H Pham, C Bechtold, E Quijano, Raman Bahal, K Dhuri
Research Type: Journal Article

Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy.
2020
K Dhuri, A Gupta, A Waghmode, A Wahane, A Kapphahn, Raman Bahal
Research Type: Journal Article

Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation
2020
Research Type: Journal Article

Emerging Therapeutic Modalities against COVID-19
2020
Raman Bahal, Jose E Manautou, Anisha Gupta, xiaobo zhong, Shipra Malik, Theodore Rasmussen
Research Type: Journal Article

Next generation microRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticle
2020
Research Type: Patent and Intellectual Property

Efficacious bicelle/PNA nanodisc for antisense
2020
Raman Bahal, Shipra Malik, Mu-ping Nieh, Armin Rad
Research Type: Poster/Presentation